Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Advancements of Microbiology
Volume 60 (2021): Issue 4 (December 2021)
Open Access
The European Medicines Agency Approved the New Antibacterial Drugs – Response to the 2017 Who Report on the Global Problem of Multi-Drug Resistance
Joanna Krajewska
Joanna Krajewska
and
Agnieszka Ewa Laudy
Agnieszka Ewa Laudy
| Dec 30, 2021
Advancements of Microbiology
Volume 60 (2021): Issue 4 (December 2021)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 30, 2021
Page range:
249 - 264
Received:
Jul 01, 2021
Accepted:
Sep 01, 2021
DOI:
https://doi.org/10.21307/pm-2021.60.4.20
Keywords
delafloxacin
,
eravacycline
,
β-lactamases inhibitors
,
siderophores
,
vaborbactam
© 2021 Joanna Krajewska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.